The listing price prediction of Anthem Biosciences IPO is Rs 727, this translates a percentage of 27.54 per cent. On the last 16 sessions grey market activities, the lowest GMP is Rs 0, while the ...

Anthem Biosciences' initial public offering (IPO) was subscribed 63.86 times, largely due to strong support from qualified institutional buyers (QIBs).

Anthem Biosciences IPO oversubscribed 63.86 times, attracting strong QIB support, raising ₹1,016 crore from anchor investors.

Anthem Biosciences’ ₹3,395-crore IPO saw strong investor demand, with overall subscription at 63.86x, signaling robust interest in the pharma CDMO sector.

Anthem Biosciences' IPO ended on 16 July, with the issue booked over 60 times. Strong demand from qualified institutional ...

Anthem Biosciences' Rs 3,395 crore IPO was subscribed 63.86 times, exceeding expectations. QIBs showed strong interest, while ...

Anthem Biosciences Ltd's IPO was subscribed 63.86 times by closing day, driven by institutional buyers. The Rs 3,395-crore ...

Following the close of the subscription of initial public offering (IPO) of Anthem Biosciences Limited, all eyes of the ...

Anthem Biosciences Ltd, a CRDMO founded in 2006, offers end-to-end drug discovery-to-manufacturing services and specialises ...

Bengaluru-based Anthem Biosciences' initial public offering (IPO) has been subscribed nearly 10 times on its final day, indicating a 27% listing premium.

The Anthem Biosciences IPO, starting July 14, 2025, aims to raise ₹3,395 crore through an Offer for Sale of 5.96 crore shares by existing shareholders, without proceeds going to the company. Shares ...

Anthem Biosciences is selling its shares in the price band of Rs 540-570, applied for a minimum of 26 shares and its ...